// App-Quantinova.ai

5398 : Apelinergic signalling in hepatocellular carcinoma (HCC: A new therapeutic treatment option

Researchers

Presenter

  • Jamie Beaumont

Principal Investigators

  • Eric Aboagye

  • Beata Wojciak-Stothard

  • Gilberto Serrano-De-Almeida

  • Robert Glen

  • Rohini Sharma

Medical Centers

  • Imperial College, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • Liver cancer

  • Solid malignancies

  • Cirrhosis

Biomarkers

  • HIF 1 alpha

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved